ticlopidine has been researched along with Shock, Septic in 6 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
Excerpt | Relevance | Reference |
---|---|---|
"Transient pancytopenia as an adverse hematologic reaction due to ticlopidine." | 7.73 | [Transient pancytopenia due to ticlopidine--a case report]. ( Barg, W; Biełous-Wilk, A; Chmielowicz, B; Grabowski, M; Kopec, A; Panaszek, B, 2005) |
"Transient pancytopenia as an adverse hematologic reaction due to ticlopidine." | 3.73 | [Transient pancytopenia due to ticlopidine--a case report]. ( Barg, W; Biełous-Wilk, A; Chmielowicz, B; Grabowski, M; Kopec, A; Panaszek, B, 2005) |
" By these criteria, we have observed a different degree of anaphylactic reaction depending on the genetic background of the hosts as well as a protection against anaphylactic shock using the antiserotoninic cyproheptadine and, to a lesser extent, by the platelet antiaggregant ticlopidine." | 3.67 | [Quantification (by nomograms) of physiopathological parameters in an experimental model of passive anaphylaxis caused by immune complexes]. ( Díaz, R; Portolés, A; Rojo, JM, 1984) |
"Atherosclerosis is considered as a moderate systemic inflammation and we hypothesise that this chronic condition could have an impact on the outcome in sepsis." | 1.39 | Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. ( Boettel, J; Breuel, H; Kabisch, B; Lösche, W; Otto, GP; Sossdorf, M; Winning, J, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Winning, J | 2 |
Reichel, J | 1 |
Eisenhut, Y | 1 |
Hamacher, J | 1 |
Kohl, M | 1 |
Deigner, HP | 1 |
Claus, RA | 1 |
Bauer, M | 1 |
Lösche, W | 2 |
Otto, GP | 1 |
Sossdorf, M | 1 |
Boettel, J | 1 |
Kabisch, B | 1 |
Breuel, H | 1 |
Grabowski, M | 1 |
Barg, W | 1 |
Biełous-Wilk, A | 1 |
Kopec, A | 1 |
Chmielowicz, B | 1 |
Panaszek, B | 1 |
Portolés, A | 1 |
Rojo, JM | 1 |
Díaz, R | 1 |
Yeh, SP | 1 |
Hsueh, EJ | 1 |
Wu, H | 1 |
Wang, YC | 1 |
Thörne, LJ | 1 |
Jönsson, BA | 1 |
Norgren, L | 1 |
Strand, SE | 1 |
1 review available for ticlopidine and Shock, Septic
Article | Year |
---|---|
Ticlopidine-associated aplastic anemia. A case report and review of literature.
Topics: Adrenal Cortex Hormones; Aged; Anemia, Aplastic; Fatal Outcome; Granulocyte Colony-Stimulating Facto | 1998 |
5 other studies available for ticlopidine and Shock, Septic
Article | Year |
---|---|
Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms.
Topics: Adult; Aged; Animals; Cell Line; Clopidogrel; Female; Fibrin; Gene Expression Profiling; Hemodynamic | 2009 |
Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Blood Coagulation; Clopidog | 2013 |
[Transient pancytopenia due to ticlopidine--a case report].
Topics: Aged; Anti-Bacterial Agents; Female; Fibrinolytic Agents; Heart Failure; Humans; Pancytopenia; Pneum | 2005 |
[Quantification (by nomograms) of physiopathological parameters in an experimental model of passive anaphylaxis caused by immune complexes].
Topics: Anaphylaxis; Animals; Cyproheptadine; Immune Complex Diseases; Mathematics; Mice; Mice, Inbred Strai | 1984 |
Effect of ticlopidine and prostaglandin E on endotoxin-induced pulmonary platelet sequestration in vivo.
Topics: Alprostadil; Animals; Anticoagulants; Blood Platelets; Endotoxins; Indium; Lung; Platelet Aggregatio | 1986 |